lung cancer
Conditions
Interventions
None listed
Sponsors
West Japan Oncology Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Stage IV lung cancer according to TNM classification 8th edition 2) Patients who were first diagnosed with the above at a participating institution between January 1, 2016 and December 31, 2020.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival, and accuracy of overall survival prediction model created by machine learning | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of patients treated with anti-cancer therapy Time to treatment failure Progression-free survival Severe adverse events Factors related to prognosis Percentage of missing values | — |
Countries
Japan
Contacts
Public ContactShinichiro Nakamura
West Japan Oncology Group WJOG datacenter
Outcome results
None listed